Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1147180

registered interest
date	30/09/2019
answering body	Ministry of Defence
answering dept id	11
answering dept short name	Defence
answering dept sort name	Defence
hansard heading	Ministry of Defence: Chief Scientific Advisers
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Defence, how many meetings he had with his Department’s Chief Scientific Adviser from 1 June to 31 August 2019.
tabling member constituency	North Norfolk
tabling member printed	Norman Lamb
uin	292154
answer	answer is ministerial correction date of answer 03/10/2019 answer text <p>Between 1 June 2019 and 31 August 2019 - there have been no meetings between the Secretary of State for Defence and the Department's Chief Scientific Adviser (CSA).</p><p>The CSA oversees a network of Scientific Advisers deployed in Front Line Commands and across Defence, providing scientific advice at all levels. Additionally, CSA is a member of the top-level governance groups in the Ministry of Defence such as the Investment Approvals Board and Executive Committee. As such, there are many opportunities to ensure advice to Ministers has benefited from scientific advice in addition to 1:1 meetings between the CSA and Ministers.</p> answering member constituency Berwick-upon-Tweed answering member printed Anne-Marie Trevelyan question first answered 03/10/2019 14:25:49 answering member 4531 label Biography information for Anne-Marie Trevelyan
tabling member	1439 label Biography information for Norman Lamb

1147190

registered interest
date	30/09/2019
answering body	Northern Ireland Office
answering dept id	21
answering dept short name	Northern Ireland
answering dept sort name	Northern Ireland
hansard heading	Northern Ireland Office: Chief Scientific Advisers
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Northern Ireland, how many meetings he had with his Department’s Chief Scientific Adviser from 1 June to 31 August 2019.
tabling member constituency	North Norfolk
tabling member printed	Norman Lamb
uin	292160
answer	answer is ministerial correction date of answer 04/10/2019 answer text <p>The Northern Ireland Office does not have a Departmental Chief Scientific Adviser.</p> answering member constituency Skipton and Ripon answering member printed Julian Smith question first answered 04/10/2019 11:04:15 answering member 4118 label Biography information for Julian Smith
tabling member	1439 label Biography information for Norman Lamb

1143605

registered interest
date	02/09/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	HIV Infection: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to (a) raise awareness of and (b) increase access to the PrEP impact trial in BAME communities.
tabling member constituency	North Norfolk
tabling member printed	Norman Lamb
uin	285065
answer	answer is ministerial correction date of answer 05/09/2019 answer text <p>A core function of the pre-exposure prophylaxis (PrEP) Impact Trial Community Advisory Board (CAB) is to raise awareness and uptake of PrEP in key populations including women and black, Asian and minority ethnic (BAME) communities. Further information about PrEP Impact Trial CAB activities and participating community groups can be found at the following links:</p><p><a href="https://www.england.nhs.uk/commissioning/spec-services/npc-crg/blood-and-infection-group-f/f03/prep-trial-updates/" target="_blank">https://www.england.nhs.uk/commissioning/spec-services/npc-crg/blood-and-infection-group-f/f03/prep-trial-updates/</a></p><p><a href="https://www.prepimpacttrial.org.uk/faqs" target="_blank">https://www.prepimpacttrial.org.uk/faqs</a></p><p>In addition, Public Health England’s Innovation Fund has supported a number of community based projects aimed at increasing PrEP awareness in women, BAME groups and trans communities; information on the projects funded in 2018 can be found at the following links:</p><p><a href="https://www.gov.uk/government/news/innovative-hiv-prevention-projects-reached-170000-people-in-2018" target="_blank">https://www.gov.uk/government/news/innovative-hiv-prevention-projects-reached-170000-people-in-2018</a></p><p>Since the start of the PrEP Impact Trial in October 2017, over half of the available 26,000 trial places have been filled. As of 3 September 2019, all participating Trial clinics were open to recruitment for women, trans men and heterosexual men. Information on the enrolment status of participating clinics is regularly updated on the PrEP Impact Trial website at the following link:</p><p><a href="https://www.prepimpacttrial.org.uk/join-the-trial" target="_blank">https://www.prepimpacttrial.org.uk/join-the-trial</a></p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 285069 question first answered 05/09/2019 15:28:31 answering member 4380 label Biography information for Jo Churchill
tabling member	1439 label Biography information for Norman Lamb

1143606

registered interest
date	02/09/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	HIV Infection: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to (a) raise awareness of and (b) increase access to the PrEP impact trial amongst women at high risk of contracting HIV.
tabling member constituency	North Norfolk
tabling member printed	Norman Lamb
uin	285069
answer	answer is ministerial correction date of answer 05/09/2019 answer text <p>A core function of the pre-exposure prophylaxis (PrEP) Impact Trial Community Advisory Board (CAB) is to raise awareness and uptake of PrEP in key populations including women and black, Asian and minority ethnic (BAME) communities. Further information about PrEP Impact Trial CAB activities and participating community groups can be found at the following links:</p><p><a href="https://www.england.nhs.uk/commissioning/spec-services/npc-crg/blood-and-infection-group-f/f03/prep-trial-updates/" target="_blank">https://www.england.nhs.uk/commissioning/spec-services/npc-crg/blood-and-infection-group-f/f03/prep-trial-updates/</a></p><p><a href="https://www.prepimpacttrial.org.uk/faqs" target="_blank">https://www.prepimpacttrial.org.uk/faqs</a></p><p>In addition, Public Health England’s Innovation Fund has supported a number of community based projects aimed at increasing PrEP awareness in women, BAME groups and trans communities; information on the projects funded in 2018 can be found at the following links:</p><p><a href="https://www.gov.uk/government/news/innovative-hiv-prevention-projects-reached-170000-people-in-2018" target="_blank">https://www.gov.uk/government/news/innovative-hiv-prevention-projects-reached-170000-people-in-2018</a></p><p>Since the start of the PrEP Impact Trial in October 2017, over half of the available 26,000 trial places have been filled. As of 3 September 2019, all participating Trial clinics were open to recruitment for women, trans men and heterosexual men. Information on the enrolment status of participating clinics is regularly updated on the PrEP Impact Trial website at the following link:</p><p><a href="https://www.prepimpacttrial.org.uk/join-the-trial" target="_blank">https://www.prepimpacttrial.org.uk/join-the-trial</a></p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 285065 question first answered 05/09/2019 15:28:31 answering member 4380 label Biography information for Jo Churchill
tabling member	1439 label Biography information for Norman Lamb

1140582

registered interest
date	19/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when he plans to issue guidance to health professionals on the Serious Shortage Protocol.
tabling member constituency	North Norfolk
tabling member printed	Norman Lamb
uin	279389
answer	answer is ministerial correction date of answer 26/07/2019 answer text <p>A Serious Shortage Protocol is an additional tool to manage serious medication shortages and may be used in the exceptional and rare situation when other measures have been exhausted or are likely to be ineffective.</p><p>At present we are currently working on the governance process for developing Serious Shortage Protocols, should one be required, through engagement, including with professional bodies and patient groups. Following this we will issue guidance to health professionals in due course.</p><p>The Pharmaceutical Services Negotiating Committee, the organisation who represent National Health Service community pharmacy contractors in England, have developed a briefing note to support community pharmacies, who will need to consider training and changes to their standard operating-procedures to take account of the potential new processes.</p><p>Any Serious Shortage Protocol would be developed by senior, specialist doctors and pharmacists, with input from national experts, Royal Colleges and specialist societies. If a Serious Shortage Protocol is to be authorised then there will also be engagement with the relevant patient groups, who can assist in informing patients. Pharmacists still have to use their professional judgment as to whether supplying against the protocol rather than the prescription is appropriate and provide the patient with relevant information. If they determine supply is not appropriate, then the patient should be referred back to their prescriber.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 26/07/2019 11:34:54 answering member 4455 label Biography information for Seema Kennedy previous answer version 131086 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
tabling member	1439 label Biography information for Norman Lamb

1140584

registered interest
date	19/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans the Government has provide information to patients on changes to the provision of medicines as a result of the serious shortage protocol; and if he will make a statement.
tabling member constituency	North Norfolk
tabling member printed	Norman Lamb
uin	279390
answer	answer is ministerial correction date of answer 26/07/2019 answer text <p>A Serious Shortage Protocol is an additional tool to manage serious medication shortages and may be used in the exceptional and rare situation when other measures have been exhausted or are likely to be ineffective.</p><p>At present we are currently working on the governance process for developing Serious Shortage Protocols, should one be required, through engagement, including with professional bodies and patient groups. Following this we will issue guidance to health professionals in due course.</p><p>The Pharmaceutical Services Negotiating Committee, the organisation who represent National Health Service community pharmacy contractors in England, have developed a briefing note to support community pharmacies, who will need to consider training and changes to their standard operating-procedures to take account of the potential new processes.</p><p>Any Serious Shortage Protocol would be developed by senior, specialist doctors and pharmacists, with input from national experts, Royal Colleges and specialist societies. If a Serious Shortage Protocol is to be authorised then there will also be engagement with the relevant patient groups, who can assist in informing patients. Pharmacists still have to use their professional judgment as to whether supplying against the protocol rather than the prescription is appropriate and provide the patient with relevant information. If they determine supply is not appropriate, then the patient should be referred back to their prescriber.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 279391 question first answered 26/07/2019 11:36:12 answering member 4455 label Biography information for Seema Kennedy previous answer version 131087 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
tabling member	1439 label Biography information for Norman Lamb

1140585

registered interest
date	19/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions the Government has had with (a) patient groups and (b) professional bodies on the development of the serious shortage protocol.
tabling member constituency	North Norfolk
tabling member printed	Norman Lamb
uin	279391
answer	answer is ministerial correction date of answer 26/07/2019 answer text <p>A Serious Shortage Protocol is an additional tool to manage serious medication shortages and may be used in the exceptional and rare situation when other measures have been exhausted or are likely to be ineffective.</p><p>At present we are currently working on the governance process for developing Serious Shortage Protocols, should one be required, through engagement, including with professional bodies and patient groups. Following this we will issue guidance to health professionals in due course.</p><p>The Pharmaceutical Services Negotiating Committee, the organisation who represent National Health Service community pharmacy contractors in England, have developed a briefing note to support community pharmacies, who will need to consider training and changes to their standard operating-procedures to take account of the potential new processes.</p><p>Any Serious Shortage Protocol would be developed by senior, specialist doctors and pharmacists, with input from national experts, Royal Colleges and specialist societies. If a Serious Shortage Protocol is to be authorised then there will also be engagement with the relevant patient groups, who can assist in informing patients. Pharmacists still have to use their professional judgment as to whether supplying against the protocol rather than the prescription is appropriate and provide the patient with relevant information. If they determine supply is not appropriate, then the patient should be referred back to their prescriber.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 279390 question first answered 26/07/2019 11:36:13 answering member 4455 label Biography information for Seema Kennedy previous answer version 131085 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
tabling member	1439 label Biography information for Norman Lamb

1139710

registered interest
date	17/07/2019
answering body	Department for International Development
answering dept id	20
answering dept short name	International Development
answering dept sort name	International Development
hansard heading	Developing Countries: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for International Development, what steps his Department is taking to support developing countries' national plans to deliver universal health coverage.
tabling member constituency	North Norfolk
tabling member printed	Norman Lamb
uin	278415
answer	answer is ministerial correction date of answer 22/07/2019 answer text <p>The UK Government provides funding to the World Health Organisation through the universal health coverage (UHC) partnership programme, along with the EU, Japan and other donors. This supports the development of UHC country plans to help countries to prioritise their own pathway to achieve UHC. Over 60 countries have now developed these plans and we are advocating use of the plans to drive greater coordination of efforts from other multilaterals.</p> answering member constituency South West Wiltshire answering member printed Dr Andrew Murrison question first answered 22/07/2019 16:22:09 answering member 1466 label Biography information for Dr Andrew Murrison
tabling member	1439 label Biography information for Norman Lamb

1139712

registered interest
date	17/07/2019
answering body	Department for International Development
answering dept id	20
answering dept short name	International Development
answering dept sort name	International Development
hansard heading	Developing Countries: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for International Development, whether his Department has plans to encourage governments of developing countries to invest five per cent of GDP in primary healthcare.
tabling member constituency	North Norfolk
tabling member printed	Norman Lamb
uin	278416
answer	answer is ministerial correction date of answer 22/07/2019 answer text <p>The UK is a global champion for Universal Health Coverage; one of the key ways to deliver the health-related SDGs and climate resilient, sustainable development more broadly. At the UN High-Level Meeting on Universal Health Coverage this September, the UK will be a strong advocate for increased domestic resources for primary health care and prevention and is pushing for positive commitments in this regard.</p> answering member constituency South West Wiltshire answering member printed Dr Andrew Murrison question first answered 22/07/2019 16:22:52 answering member 1466 label Biography information for Dr Andrew Murrison
tabling member	1439 label Biography information for Norman Lamb

1138829

registered interest
date	15/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Mental Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans his Department has to improve support for people with neurodevelopmental conditions.
tabling member constituency	North Norfolk
tabling member printed	Norman Lamb
uin	277125
answer	answer is ministerial correction date of answer 18/07/2019 answer text <p>The Government is committed to supporting people with neurodevelopmental conditions to live well. We are currently reviewing the adult autism strategy and working with the Department of Education will be extending the scope of the strategy to include children. The refreshed strategy will be published by the end of the year. We are also working closely with the National Institute for Health and Care Excellence (NICE) and their attention deficit hypersensitivity disorder (ADHD) Implementation Working Group to look at how the current NICE guidance and quality standard on ADHD are being implemented. This work includes looking to identify best practice and examples of innovation, which have improved outcomes for people with ADHD, so that these can be widely disseminated to commissioners to improve local practice. We are considering what actions can be taken to support those with other neurodevelopmental conditions.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 18/07/2019 09:28:06 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	1439 label Biography information for Norman Lamb